TELIF (Telescope Innovations) EBITDA: $-2.12 Mil (TTM As of May. 2026)


TELIF Telescope Innovations Corp TELIF
31 GF Score
Price $0.58
GF Value $0.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Telescope Innovations EBITDA?

Telescope Innovations TELIF -0.69% 31 EBITDA is $-2.12 Mil as of May. 2026. GuruFocus rates TELIF with a GF Score™ of 31/100 and a GF Value™ of $0.40 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Telescope Innovations's EBITDA for the three months ended in May. 2026 was $-0.79 Mil. Its EBITDA for the trailing twelve months (TTM) ended in May. 2026 was $-2.12 Mil.

During the past 3 years, the average EBITDA Growth Rate was 52.50% per year. During the past 5 years, the average EBITDA Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 7 years, the highest 3-Year average EBITDA Growth Rate of Telescope Innovations was 52.50% per year. The lowest was -42.90% per year. And the median was 51.60% per year.

Telescope Innovations's EBITDA per Share for the three months ended in May. 2026 was $-0.01. Its EBITDA per share for the trailing twelve months (TTM) ended in May. 2026 was $-0.03.

During the past 3 years, the average EBITDA per Share Growth Rate was 54.00% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 7 years, the highest 3-Year average EBITDA per Share Growth Rate of Telescope Innovations was 54.00% per year. The lowest was -38.70% per year. And the median was 52.50% per year.

Telescope Innovations  (OTCPK:TELIF) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Telescope Innovations EBITDA Related Terms


Telescope Innovations EBITDA Historical Data

* Premium members only.

The historical data trend for Telescope Innovations's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations EBITDA Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24 Aug25
EBITDA
Get a 7-Day Free Trial -3.19 -4.24 -0.31 -0.34 -0.43

Telescope Innovations Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 0.18 -0.75 -0.76 -0.79

TELIF vs VRTX, REGN, ALNY: EBITDA Comparison

For the Biotechnology subindustry, Telescope Innovations's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telescope Innovations EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's EV-to-EBITDA falls into.


TELIF
31GF Score
Telescope Innovations Corp TELIF
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Telescope Innovations's EBITDA for the fiscal year that ended in Aug. 2025 is calculated as

Telescope Innovations's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Aug. 2025, Telescope Innovations's EBITDA was $-0.43 Mil.

Telescope Innovations's EBITDA for the quarter that ended in May. 2026 is calculated as

Telescope Innovations's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in May. 2026, Telescope Innovations's EBITDA was $-0.79 Mil.

EBITDA for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of $-2.12 Mil mean?
Telescope Innovations (TELIF) has a EBITDA of $-2.12 Mil as of May. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Telescope Innovations.
Is Telescope Innovations' EBITDA too high?
Telescope Innovations' current EBITDA is $-2.12 Mil. Overall, Telescope Innovations has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' EBITDA compare to VRTX and REGN?
Telescope Innovations' EBITDA of $-2.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Biotechnology company?
A good EBITDA depends on the Biotechnology industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Telescope Innovations. Telescope Innovations's current EBITDA is $-2.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.40, compared to a current price of $0.58 — trading 44% above its estimated fair value. The current EBITDA is $-2.12 Mil. Telescope Innovations' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current EBITDA is $-2.12 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.58 is trading 44% above its estimated GF Value™ of $0.40. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • EBITDA: $-2.12 Mil
  • GF Value™: $0.40 vs. price of $0.58 (44% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
31GF Score

Get the complete analysis for TELIF

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.40
GF Value